Clinical trial Recruiting at 1 site Interventional Ages 19 to 90

Reversing muscle paralysis in critically ill patients

Official title: Effect of Neuromuscular Reversal Agents on Time for Neurological Assessment After Endotracheal Intubation in Critically Ill Patients

Run by Seoul National University Hospital · NCT05993390 · Data updated 2026-11-12

This study is testing whether different medications can help critically ill patients recover faster from muscle paralysis after being intubated.

Quick facts

Study typeInterventional
Ages19 Years to 90 Years
SexAll
Enrollment30 (estimated)
SponsorSeoul National University Hospital
Academic / other
Locations1 site (Seoul, Jongno-gu)
StatusRecruiting
StartedJanuary 11, 2024
Main results expectedAugust 31, 2027
Study endsApril 30, 2028
Registry record updatedJune 2, 2026
Trial IDNCT05993390 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adult patients aged 19 years or older who have been intubated in the intensive care unit.

Probably not a fit

Patients with pre-existing neurological dysfunction or neuromuscular disorders may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to evaluate the effectiveness of different reversal agents for neuromuscular blockade in critically ill patients who have undergone endotracheal intubation. Participants will be randomly assigned to receive either sugammadex, neostigmine, or no medication, and the time taken for neurological assessment will be measured. The study will monitor the Glasgow Coma Scale (GCS) and other neurological indicators to determine the impact of these agents on recovery time. The goal is to identify which agent, if any, facilitates quicker neurological recovery.

Why it matters

Potential benefit: If successful, this study could lead to faster neurological assessments and improved outcomes for critically ill patients after intubation.

How similar studies have gone: Other studies have shown varying success with reversal agents for neuromuscular blockade, making this approach both relevant and potentially impactful.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adult patients 19 years of age or older who were intubated after admission to the intensive care unit.

Exclusion Criteria:

* Patients younger than 19 years of age
* Patients who are not neurologically evaluable or have concomitant neurologic dysfunction
* Patients with neuromuscular disorder
* Patients with a history of drug allergic reactions to sugammadex or neostigmine
* Patients taking or planning to take toremifene, fusidic acid, or hormonal contraceptives

Where it's running

  • Seoul National University Hospital
    Seoul, Jongno-gu, South Korea
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.